甘露醇与高渗盐水减轻大鼠脑出血模型肿胀并调节炎症标志物
该研究在大鼠基底节胶原酶注射脑出血模型中,比较等渗甘露醇与高渗盐水(首次于脑出血诱导后5小时给药,之后每12小时一次,共4次)对死亡率、脑肿胀及小胶质细胞/巨噬细胞极化的影响。结果显示,与对照组相比,甘露醇和高渗盐水均提高输注后1小时血浆渗透压、降低48小时死亡率和半球肿胀,并减少血肿周围及对侧组织小胶质细胞/巨噬细胞活化,在血肿周围组织减少M1样标志物、增加M2样标志物、减少CD45+细胞浸润。作者认为,定期重复给予渗透性药物可能是减轻脑出血后神经炎症的辅助手段。
要点
- 大鼠脑出血模型中,造模后5小时首次给药、之后每12小时一次共4次,甘露醇和高渗盐水均降低48小时死亡率(对照组82%、甘露醇36%、高渗盐水53%)。
- 同一方案下,甘露醇和高渗盐水均降低48小时半球肿胀(对照组32%、甘露醇21%、高渗盐水17%)。
- 输注后1小时血浆渗透压:对照组301±1.5 mOsm/kg、甘露醇315±4.2 mOsm/kg、高渗盐水310±2.0 mOsm/kg。
- 血肿周围组织中小胶质细胞/巨噬细胞M1样标志物(核p65、TNF、NOS2)减少,M2样标志物(精氨酸酶、YM1、pSTAT3)增加,CD45+细胞浸润减少。
- 作者认为,定期重复给予渗透性药物可能是减轻脑出血后神经炎症的辅助手段。
适用人群与场景
- 大鼠基底节胶原酶注射脑出血模型,采用高剂量与中等剂量胶原酶注射分别对应高死亡率和低死亡率。
处置流程与药物剂量
- 等渗甘露醇和高渗盐水首次于脑出血诱导后5小时给药,之后每12小时给药一次,共4次。
研究设计与关键结果
- 研究类型为大鼠脑出血模型实验;干预为等渗甘露醇和高渗盐水,对照为对照组;给药方案为造模后5小时首次给药、之后每12小时一次、共4次。
- 输注后1小时血浆渗透压:对照组301±1.5 mOsm/kg、甘露醇315±4.2 mOsm/kg、高渗盐水310±2.0 mOsm/kg。
- 48小时死亡率:对照组82%、甘露醇36%、高渗盐水53%。
- 48小时半球肿胀:对照组32%、甘露醇21%、高渗盐水17%。
- 血肿周围和对侧组织中,甘露醇和高渗盐水均减少Iba1+细胞丰度并改变其形态,提示小胶质细胞/巨噬细胞活化减少。
- 血肿周围组织中,甘露醇和高渗盐水减少M1样标志物(核p65、TNF、NOS2),增加M2样标志物(精氨酸酶、YM1、pSTAT3),并减少CD45+细胞浸润。
证据类型、等级与局限
- 证据类型:动物实验(大鼠脑出血模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,定期重复给予渗透性药物可能是减轻脑出血后神经炎症的辅助手段。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Spontaneous intracerebral hemorrhage (ICH) leaves most survivors dependent at follow-up. The importance of promoting M2-like microglial responses is increasingly recognized as a key element to ameliorate brain injury following ICH. The osmotherapeutic agents, mannitol and hypertonic saline (HTS), which are routinely used to reduce intracranial pressure, have been shown to reduce neuroinflammation in experimental ischemic and traumatic brain injury, but anti-inflammatory effects of osmotherapies have not been investigated in ICH.
METHODS: We studied the effects of iso-osmotic mannitol and HTS in rat models of ICH utilizing high-dose and moderate-dose collagenase injections into the basal ganglia, associated with high and low mortality, respectively. We studied the effects of osmotherapies, first given 5 h after ICH induction, and then administered every 12 h thereafter (4 doses total). Immunohistochemistry was used to quantify microglial activation and polarization.
RESULTS: Compared to controls, mannitol and HTS increased plasma osmolarity 1 h after infusion (301 ± 1.5, 315 ± 4.2 and 310 ± 2.0 mOsm/kg, respectively), reduced mortality at 48 h (82, 36 and 53%, respectively), and reduced hemispheric swelling at 48 h (32, 21, and 17%, respectively). In both perihematomal and contralateral tissues, mannitol and HTS reduced activation of microglia/macrophages (abundance and morphology of Iba1 + cells), and in perihematomal tissues, they reduced markers of the microglia/macrophage M1-like phenotype (nuclear p65, TNF, and NOS2), increased markers of the microglia/macrophage M2-like phenotype (arginase, YM1, and pSTAT3), and reduced infiltration of CD45 + cells.
CONCLUSIONS: Repeated dosing of osmotherapeutics at regular intervals may be a useful adjunct to reduce neuroinflammation following ICH.
参考来源
- Schreibman DL, Hong CM, Keledjian K, et al. Mannitol and Hypertonic Saline Reduce Swelling and Modulate Inflammatory Markers in a Rat Model of Intracerebral Hemorrhage. Neurocrit Care. 2018. PMID: 29700692. doi:10.1007/s12028-018-0535-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。